The Henry Ford Health + MSU Innovation Fund invests in early-stage health care companies that are poised to transform patient care, accelerate access to innovations and deliver measurable impact. Our fund combines capital investment with deep health care expertise, access to clinical and research environments and connections to a powerful innovation ecosystem anchored by Henry Ford Health, Michigan State University, and the MSU Research Foundation.
Where innovation meets opportunity
Our Focus Areas
We invest in early-stage healthcare companies that are innovating in high-growth sectors aligned with the strengths of the Henry Ford + MSU partnership, including:
- Diagnostics & Life Science Tools and Precision Medicine – including genomic testing, biomarker discovery and personalized treatment platforms
- Health Care IT, Digital Health and AI – encompassing health care software, virtual care, predictive analytics and AI-enabled clinical decision support
- Medical Devices and Remote Monitoring – including surgical technologies, wearables, sensors and home-based diagnostics
- Therapeutics and Advanced Drug Delivery – including novel biologics and digital therapeutics
Funding Parameters
Our typical funding parameters are:
- Average first check size: $250,000 to $400,000
- Stage: Pre-seed through Series A
- Instruments: SAFEs, Convertible Notes or Preferred Stock Financings
- Follow-On Investment: Considered for high-performing portfolio companies
Eligibility Requirements
To qualify for funding, companies must:
- Be incorporated in Delaware or Michigan as a for-profit C-Corp
- Be less than five years old
- Have a connection to Henry Ford Health, Michigan State University, or the MSU Research Foundation (at time of investment or as a direct result of investment)
How to Apply
We accept applications on a rolling basis. To be considered, please complete the Innovation Hub Intake Form.